Historical aspects
Haemophilia is an inherited sex-linked disorder of blood coagulation which only affects males, and in its severe form is found in 1 in 25000 of the population. Probably the earliest description ofhaemophilia was given in tl,e 10th century by Albucasis (936-1013) in his great treatise on medicine and surgery, subsequently published in 1519. In modern times, however, the disease was not recognized until the late 18th and early 19th century when, in one of the first great North American contributions to medicine, Otto (1803) clearly described 'an haemorrhagic disposition existing in certain families' and noted that only males were affected, but that it may be transmitted by females. At least ten more cases were recorded during the next 37 years (Lane 1840), during which time the clinical signs and the immunity offemalesdespite their ability to transmit the disease -were clearly established (Nasse 1820). It was not until 1855, however, that Grandidier gave the first full clinical description of the disease and called it haemophilia.
The treatment of bleeding in haemophiliacs was for long an almost insoluble problem. Because of the deficiency of (what is now known as) Factor VIII in the plasma, no clot would form at the site of haemorrhage, which might occur spontaneously or as the result of accidental injury, dental extraction, or surgery. Neither simple pressure, nor any other conventional means of controlling blood flow, was effective, and the patients would sooner or later die from one of these uncontrollable haemorrhages. Blood transfusion -first used in haemophilia in the case discussed in this paper -proved of limited effectiveness, and it was not until the 1960s that the disease became readily controllable by transfusion of concentrated preparations of human Factor VIII. The modern treatment of haemophilia, however, has its origins in a case reported 140 years ago (Lane 1840).
The case In August 1840, in London, Samuel Lane FRCS operated upon a boy named George Firmin 'to relieve the deformity of squinting' (Lane 1840). At the time he was in ignorance of the lad's clinical history but it later transpired that 'the boy's life had been in danger several times from haemorrhage, after very slight injuries', and that at least from the age of seven he had been in hospital on several occasions for bleeding episodes following dental extractions, a cut finger, and 'an affection of the knee joint' which had been so exacerbated by the application of leeches that the leech bites had needed to be 'transfixed with needles, and ligatures tied underneath them'. Lane described his patient as suffering from 'haemorrhagic diathesis' (i.e. bleeding disorder) and noted that 'The cases on record ... are not very numerous': his description of George Firmin matches exactly the classical picture of haemophilia, and in at least one nineteenth century medical dictionary (Hoblyn 1887) the terms 'haemorrhagic diathesis' and 'haemophilia' are given as synonymous.
Following the operation, during which 'Nothing worthy of particular notice occurred ... excepting that the boy became faint, and there was more bleeding than usual', the boy walked home; but that same evening Lane was sent for 'in consequence of the recurrence of bleeding from the eye'. The boy had by then apparently been losing blood for some six or seven hours. With 'occasional intermissions' the bleeding then continued for another five nights and six days despite attempts to stop it by pressure. On the third day the bleeding was for a time controlled 'by alternate applications of powdered gum tragacanth, and beaver [fur] gathered from a hat, which with the blood formed a coagulated mass as large as the boy's head, concealing the whole orbit, and firmly adhering at its margins to the surrounding skin'. After a short while, however; 'a sudden accession of the haemorrhage removed the whole m a s s ' . '
• By the fourth day 'the boy's stomach rejected every thing he took, and he was in a state of extreme prostration', while on the fifth day 'he was in a state of almost continual syncope' and had not even the strength to eject his vomit, which nearly suffocated him. Despite a temporary respite when the bleeding was controlled for a short time by pressure, on the sixth day 'he was, if possible, in a more deplorable condition than ever; the bleeding had returned during the night; the features were shrunk; the skin was of the paleness, and almost coldness, of death; the pulse could not be felt at the wrist'. In short, the patient was clearly close to death.
In these circumstances Lane decided 'not to allow the boy to die, without giving him the chance afforded by the operation of transfusion', although this was an operation that at the time had been 'seldom witnessed by the profession'.
The transfusion
Blood transfusion had been attempted on humans, following a number of animal experiments, during the 16th century (Denis 1667 , Farr 1980 , but because animal blood had always been used the procedure had been attended by severe haemolytic reactions, and a fatality following (although not caused by) a transfusion of calfs blood had resulted in criminal proceedings against the physician (Philosophical Transactions of the Royal Society of London 1668) which effectively put a stop to human transfusion for almost 150 years. In 1818, however, James Blundell (1790-1877) -a noted physiologist, physician and obstetriciandemonstrated the mutual incompatibility of bloods of animals of different species and, using human donor blood, performed a number of successful transfusions, mostly for post-partum haemorrhage (Blundell 1825). The two colleagues with whom Blundell had joined in these early experiments had both reported cases of their own which had been successfully transfused (Waller 1825 , Doubleday 1825 ; but, although by 1829 it was alleged that 'about fourteen' transfusions of human blood had been given (all but one successfully) (Waller 1829) , there were less than a score of such cases recorded in the literature prior to Lane's decision in 1840 to try this last desperate measure upon George Firmin. Before undertaking this transfusion Lane had received 'full instructions from Dr. Blundell, who kindly, and with great perspicuity, explained to me the result of his experience with respect to the steps of the operation'.
Although Blundell had devised a number of instruments for transfusion, most of his work had been done with syringes, and the apparatus used by Lane (Figure 1 ) was a simple but effective variation on this theme supplied by Messrs Philp and Wicker of St James' Street, London (Lane 1840). The syringe -the design of which was still being used 19 years later (Waller 1860) , and which has been attributed by Keynes (1949) to that later period -was based upon a design 'made by Mr. Lloyd, an ingenious instrument-maker, residing inKing Street, Borough' and described by Waller in 1829. It consisted essentially of a tin-lined brass syringe fitted with a 2-way stopcock between a funnel for collection of the donor blood, and a tube 'of a convenient form, to enter the vein of the recipient person' (Lane 1840). The donor used by Lane ('a stout, healthy young woman') was bled by opening a vein in the arm with a lancet and then 'the young woman's arm being brought over the funnel, was allowed to bleed into it'. In an attempt to overcome coagulation the apparatus had been previously warmed by placing it in warm water. By operation of the stopcock the blood was taken into the syringe from the funnel 'and the tube attached to the syringe was introduced into the boy's vein' -a vein 'at the bend of the elbow' which had previously been cut down upon for the purposeand the blood 'propelled into the boy's system'.
Of the three great historical barriers to successful transfusion -use of animal rather than human blood, blood group incompatibility, and coagulation -only the first had been breached by 1840. Fortunately, on this occasion there were no subsequent signs of any haemolytic reaction, and thus the donor's blood group would appear to have been ABO compatible with that of George Firmin. (There would be about a 67% chance of this occurring by random selection of a UK population (Dobson & Ikin 1946) ; most individuals may, with reasonable safety, receive only blood of their own group or group 0.) Coagulation, however, continued to be the major technical problem of transfusion until the introduction of sodium citrate as an anticoagulant in 1914-15 (Agote 1915 , Lewisohn 1915 . Lane had great difficulty with coagulation, having to wash out the apparatus when the first syringe-full of blood began to clot before it could be given to the boy, and again 'four separate times the entire apparatus was removed on account of the tendency of the blood to coagulate, and warm water was passed through it'. Lane noted that 'After the young woman had lost ten or twelve ounces [about 280-340 mlJ of blood, it began to flow more slowly from her arm, and we were compelled to be satisfied with the quantity already transfused'. A considerable proportion of this donor blood had been lost due to the coagulation and Lane calculated that 'as much as five and a half ounces [about 150 mil of blood were injected into the vessels of the boy'.
The result of this transfusion was dramatic. The pulse, which had previously not been detectable, 'immediately returned at the wrist' and 'in the course of an hour or two, the boy sat up in his bed, and drank a glass of wine and water from his own hand'. There was no recurrence of the bleeding from the eye and the wound in the arm healed in about ten days. The boy, 'after being wheeled out in a hand carriage in the open air, soon recovered his appetite and strength, and, in about three weeks, went into the country; from whence he returned a few days back perfectly well, and with the eye restored to a straight position', Discussion There can be no doubt that in transfusing this haemophiliac, Lane was seeking simply to restore blood loss in a badly exsanguinated and dehydrated patient, and can have had little or no hope of staunching the continuous bleeding by this means, all other attempts having failed; yet the transfusion apparently achieved both ends. In the course of his experiments upon dogs, Blundell (1818) had already noted that the volume of blood necessary to preserve life in an exsanguinated subject was markedly less than the volume of blood lost. Although the amount transfused by Lane was small enough (even in relation to the relatively small body weight, and hence blood volume, of an eleven-year-old boy), there can be little question that in partially restoring both volume and oxygen-carrying capacity it was, literally, life-saving. Of greater interest, however, was the effect of transfusion in stopping the prolonged bleeding.
It is possible that haemostasis was achieved partially because of the nature of the blood transfused, which was taken from a young woman who was certainly under considerable stress (and would thus have had generally high levels of circulating coagulation factors) and using a technique which would have totally activated the contact factors, leading especially to high levels of Factor IX even if there would not have been much Factor VIII present. Allied to this is the suspicion that George Firmin was not a severe haemophiliac. He had already survived several haemorrhages, including one following a dental extraction, and a search of the registers of deaths in England and Wales from 1840 until 1850 has revealed no George Firmin of an age which could identify him as Samuel Lane's patient; so it seems probable that he survived at least until the age of 21.
In this particular case there was no evidence of onset of infection at the site of bleeding. The low blood volume and pressure following prolonged bleeding would have helped maintain the clot already formed in situ, and it is well recognized that external bleeding in a haemophiliac is easier to control than internal bleeding, although even in a haemarthosis, haemostasis is effected today long before theoretically haemostatic levels of circulating Factor VIII are achieved by transfusion.
It is probable that George Firmin was fortunate, for, as has recently been stressed: 'It is seldom possible to achieve effective plasma concentrations of Factor VIII using whole blood. Whole blood or packed cells are thus used to correct anaemia but must not be relied on to control bleeding' (Biggs 1974 ). Yet the fact remains that George Firmin stopped bleeding after a single transfusion of only 150 ml of fresh whole blood at the end of a period of six days almost continuous haemorrhage.
Although at the beginning of the present century it was held by some that transfusion was not successful in treating haemorrhage in haemophilia (Osler 1903) , this view did not prevail, and it became an established belief that relatively small volumes of blood were sufficient to establish haemostasis in such cases. For example, in 1922 Keynes said that 'The amount of blood to be transfused in haemophilia will vary with the age of the patient ... Ifhaemostatic effects only are wanted, 100 cc of blood will be enough'; while in 1939 Riddell suggested that 'If the transfusion is simply being used for its haemostatic effect, 200 cc of citrated blood slowly introduced will usually be as effective as larger amounts'.
It seems most probable that the modern view that a single transfusion of 100-200 ml of fresh blood would be inadequate to establish haemostasis in a bleeding haemophiliac is based upon entirely different criteria from those used in the past. In days when blood transfusion was an heroic procedure reserved for patients for whom no other possible hope of life existed (and sometimes, even, for those who had just expired: Blundell 1825) the only real criterion was pragmatic -did it work? There was no question of carefully calculated volumes being transfused to achieve and maintain optimum in vivo levels of cells or coagulation factors: dosage was empirical and because of technical difficulties with coagulation the smallest volume was given that would achieve a clinical result.
Today it is recognized that 'there is considerable variation in Factor VIII response from patient to patient irrespective of the type of therapeutic material used' (Rizza 1972) and complex formulae are invoked to calculate dosage. However, the 150 ml of fresh blood given to George Firmin certainly did save his life and -significantly -stopped further bleeding, both from his operation wound and the (substantial) wound of the transfusion.
Samuel Armstrong Lane FRCS (1802-92) was not a man who advanced blood transfusion by careful research, as had Blundell (1825). At the time of his transfusion of George Firmin he was a lecturer in anatomy and surgery at the St George's Hospital Medical School in Grosvenor Place, Hyde Park Corner, and his life was largely devoted to teaching and practising surgery (British Medical Journal 1892) . Lane went to considerable lengths to avoid gaining a reputation as a specialist in any particular area of medicine or surgery, and ifhe ever performed any other transfusions he did not report them in print. In the case considered here, however, Lane undoubtedly broke new ground in his treatment of haemophilia, and it is surprising that his role in the development of modern blood transfusion has hitherto gone almost entirely unnoticed,
